Pharmacokinetics of Darunavir/Ritonavir Once Daily and Atazanavir/Ritonavir Once Daily Over 72 Hours Following Drug Intake Cessation.
Phase of Trial: Phase I
Latest Information Update: 13 Aug 2010
At a glance
- Drugs Darunavir (Primary) ; Atazanavir; Ritonavir
- Indications HIV infections
- Focus Pharmacogenomic; Pharmacokinetics
- 13 Aug 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 13 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Apr 2010 Actual initiation date (Apr 2010) added as reported by ClinicalTrials.gov.